Chengdu Zenitar Biomedical Technology Co., Ltd

This early-phase study tested a new drug called Purinostat Mesylate in 29 people with blood cancers like lymphoma and leukemia that had returned or stopped responding to standard treatments. The goal was to check the drug's safety, find the best dose, and see how the body process…

This early-phase study tested a new drug called flonoltinib maleate in 31 people with myeloproliferative neoplasms (MPNs), a group of bone marrow cancers that includes myelofibrosis. The main goal was to check the drug's safety and find the right dose. The drug targets specific p…

This study tested a new experimental drug called ZL-82 in 41 healthy adults to see if it is safe and how the body processes it. The drug is designed to target the immune system, but this early-phase trial did not aim to treat any disease. Researchers also checked whether the drug…

This study looked at whether eating food changes how the body absorbs a new medicine called flonoltinib maleate. Twenty-four healthy adults took the drug with and without food to compare levels in the blood. The goal was to learn the best way to take the medicine, not to treat an…

This early-stage study tested the safety and how the body processes a new drug called flonoltinib maleate in 40 healthy adults in China. Participants received a single dose of the drug or a placebo, and researchers monitored side effects and drug levels in blood, urine, and stool…